Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthCare Global EnterprisesNSE:HCG +0.18%83 EV-to-EBIT is 56.48 as of Aug. 19, 2026, which is 44% above its 10-year median of 39.22. GuruFocus rates NSE:HCG with a GF Score™ of 83/100 and a GF Value™ of ₹603.63 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 474 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 89.45% on this metric.
The historical rank and industry rank for HealthCare Global Enterprises's EV-to-EBIT or its related term are showing as below:
NSE:HCG'
s EV-to-EBIT Range Over the Past 10 Years
Min: -80 Med: 39.22 Max: 486.55
Current: 56.47
During the past 12 years, the highest EV-to-EBIT of HealthCare Global Enterprises was 486.55. The lowest was -80.00. And the median was 39.22.
NSE:HCG's EV-to-EBIT is ranked worse than 89.45% of 474
companies
in the Healthcare Providers & Services industry
Industry Median: 15.98
vs NSE:HCG: 56.47
HealthCare Global Enterprises (NSE:HCG) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
HealthCare Global Enterprises's Enterprise Value for the quarter that ended in Jun. 2026 was ₹93,627 Mil.
HealthCare Global Enterprises's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,110 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises EV-to-EBIT Related Terms
HealthCare Global Enterprises EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's EV-to-EBIT falls into.
HealthCare Global Enterprises's current Enterprise Value is ₹119,163 Mil.
HealthCare Global Enterprises's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,110 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises (NSE:HCG) has a EV-to-EBIT of 56.48 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on HealthCare Global Enterprises and its competitors. This is 44% above median its historical median of 39.22. According to the industry distribution chart, HealthCare Global Enterprises ranks #424 out of 474 companies in the Healthcare Providers & Services industry, placing it in the top 89.5%.
Is HealthCare Global Enterprises' EV-to-EBIT too high?
HealthCare Global Enterprises' current EV-to-EBIT of 56.48 is 44% above median its 10-year median of 39.22. The Healthcare Providers & Services industry median EV-to-EBIT is 15.98. HealthCare Global Enterprises' value of 56.48 is 253.4% above this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #424 out of 474 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HealthCare Global Enterprises has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #424 out of 474 companies for EV-to-EBIT. This places HealthCare Global Enterprises in the lower half of its industry. The industry median EV-to-EBIT is 15.98. HealthCare Global Enterprises' value of 56.48 is 253.4% above this benchmark. While the company's 10-year median is 39.22 vs. the industry median of 15.98, HealthCare Global Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.98, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current EV-to-EBIT of 56.48 is 253.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current EV-to-EBIT is 56.48, which is 44% above median its own 10-year median of 39.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹603.63, compared to a current price of ₹713.65 — trading 18.2% above its estimated fair value. The current EV-to-EBIT is 56.48, which is 44% above median its 10-year median of 39.22 and 253.4% above the Healthcare Providers & Services industry median of 15.98. HealthCare Global Enterprises' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current EV-to-EBIT is 56.48 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹713.65 is trading 18.2% above its estimated GF Value™ of ₹603.63.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
EV-to-EBIT: 56.48 (44% above median its 10-year median of 39.22)
GF Value™: ₹603.63 vs. price of ₹713.65 (18.2% above fair value)
Industry Position: 253.4% above the Healthcare Providers & Services median (#424 of 474)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
83GF Score
Get the complete analysis for NSE:HCG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
